Global private equity and venture capital news and research

Posts Tagged ‘Apposite Capital’

14 January 2015

New Leaf, Apposite to exit biotech company Convergence to trade partner

four-leaf-clovers-1381213-m The venture capital backers of UK biotechnology company Convergence Pharmaceuticals have reportedly agreed to sell their stakes to Nasdaq-listed Biogen Idec for $675m.

27 June 2014

Apposite could make more than 20x return from Ulthera exit

skin Healthcare-focused investor Apposite Capital has exited Ulthera with expected returns set to top 20 times if the company meets certain milestones.

28 March 2014

Venture firms renew commitment to RuiYi through $15m Series B round

dna Sino-American medical research business RuiYi has picked up another $15m of financing through a Series B round thanks to renewed commitments from its existing backers.

23 July 2013

Apposite exits ultrasound device maker Zonare to China’s Mindray Medical

ultrasound Healthcare-focused private equity and venture investor Apposite Capital has sold portfolio company Zonare Medical Systems to China’s Mindray Medical International.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015